Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments - 24/02/22
Résumé |
Coronavirus disease 2019 (COVID-19)-related stressors and restrictions, in the absence of social and institutional support, have led many individuals to either increase their substance consumption or relapse. Consequently, treatment programs for substance use disorders (SUDs) made a transition from in-person to remote care delivery. This review discusses the following evidence regarding changes prompted by the COVID pandemic to the clinical care of individuals with SUDs: (1) reduction in availability of care, (2) increase in demand for care, (3) transition to telemedicine use, (4) telemedicine for treatment of opioid use disorders, and (5) considerations for use of telemedicine in treating SUDs.
Le texte complet de cet article est disponible en PDF.Keywords : COVID-19, Pandemic, Substance use disorder treatment, Opioid use disorder, Digital technology, Telemedicine
Plan
Vol 45 - N° 1
P. 95-107 - mars 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.